Levetiracetam Clinical Trials

5 actively recruiting trials across 1 location

▲ +1 trial since May 2026

Also known as: Keppra

Pipeline

Phase 2: 2Phase 3: 2Phase 4: 1

Top Sponsors

The University of Queensland1
Tata Memorial Centre1
Masonic Cancer Center, University of Minnesota1
Leiden University Medical Center1
Beijing Tiantan Hospital1

Indications

Cancer4
Postoperative Seizures After Brain Tumor Surgery1
Parkinson's Disease1
High Grade Non-Hodgkin's Lymphoma, Adult1
Fetal Hemoglobin1

Other4 trials

Levetiracetam for Seizure Prevention After Brain Tumor Surgery

Phase 3

Seizure Treatment in Glioma

Phase 4

Short Versus Long-term Levetiracetam in Brain Tumors

Phase 3

Uncovering a Novel Therapeutic Target to Reduce Dementia Risk in Parkinson's Disease

Phase 2

Minneapolis, Minnesota1 trial

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

University of Minnesota Masonic Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.